Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and ...

Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

Ozempic is synonymous with weight loss for many people, even as they can turn to drugs with other brand names that have been tailored to treat obesity. The blockbuster Type 2 diabetes medication ...

Semaglutide was a top-selling drug in 2023, and its popularity only continues to grow, as it’s been increasingly prescribed off-label for weight loss via brands like Ozempic. Read on to learn ...

As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...